diminazene and Arrhythmia

diminazene has been researched along with Arrhythmia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	3 (75.00)	2.80

Authors

Authors	Studies
Coutinho, DCO; Cruz, JS; Ferreira, AJ; Foureaux, G; Joviano-Santos, JV; Martins-Júnior, PA; Medei, E; Resende, RR; Rodrigues-Ferreira, C; Santos, A; Santos, RAS; Santos-Miranda, A; Vieyra, A	1
Cruz, JS; Ferreira, AJ; Joca, HC; Joviano-Santos, JV; Santos-Miranda, A	1
Duan, W; Liu, J; Ma, Y; Xia, L; Yu, S; Zhai, M; Zhang, L; Zhu, H	1
Coutinho, DC; Ferreira, AJ; Medei, E; Monnerat-Cahli, G	1

Reviews

2 review(s) available for diminazene and Arrhythmia

Article	Year
Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury. Peptides, 2022, Volume: 151 Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Diminazene; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury	2022
The role of SARS-CoV-2 target ACE2 in cardiovascular diseases. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:3 Topics: Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Diminazene; Heart Failure; Humans; Hypertension; Myocardial Infarction; Recombinant Proteins	2021

Other Studies

2 other study(ies) available for diminazene and Arrhythmia

Article	Year
Diminazene aceturate (DIZE) has cellular and in vivo antiarrhythmic effects. Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diminazene; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Rats, Wistar	2020
Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:11 Topics: Action Potentials; Angiotensin-Converting Enzyme 2; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diminazene; Enzyme Activation; Enzyme Activators; Heart Conduction System; Heart Rate; Heart Ventricles; Hyperglycemia; Male; Peptidyl-Dipeptidase A; Rats, Wistar; Streptozocin; Time Factors	2014

Article

Year

Diminazene aceturate (DIZE) has cellular and in vivo antiarrhythmic effects.

Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:2

Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diminazene; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Rats, Wistar

2020

Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:11

Topics: Action Potentials; Angiotensin-Converting Enzyme 2; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diminazene; Enzyme Activation; Enzyme Activators; Heart Conduction System; Heart Rate; Heart Ventricles; Hyperglycemia; Male; Peptidyl-Dipeptidase A; Rats, Wistar; Streptozocin; Time Factors

2014